subject_id=ML_04;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_04;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_05;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_05;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_07;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_07;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_09;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_09;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_10;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_10;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_14;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_14;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_17;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_17;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_18;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_18;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_21;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_21;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_23;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_23;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_24;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_24;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_28;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_28;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_29;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_29;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_30;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_30;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_34;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_34;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_36;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_36;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_37;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_37;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_39;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_39;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_41;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_41;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_42;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_42;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_44;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_44;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_45;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_45;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_50;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_50;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_52;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_52;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_53;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_53;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_55;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_55;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_59;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_59;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_62;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_62;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_63;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_63;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_64;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_64;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_66;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_66;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_67;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_67;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_68;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_68;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_69;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_69;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_73;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_73;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_74;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_74;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_76;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_76;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_77;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_77;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_79;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_79;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_81;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_81;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_86;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_86;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_87;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_87;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_91;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_91;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_92;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_92;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_93;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_93;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_94;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_94;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_95;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_95;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_96;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_96;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_97;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_97;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_98;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_98;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_99;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_99;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_06;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_06;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_08;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_08;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_12;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_12;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_72;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_72;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_31;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_31;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_32;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_32;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_33;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_33;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_38;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_38;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_43;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_43;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_47;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_47;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_75;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_75;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_89;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_89;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_102;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_102;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_103;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_103;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_104;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_104;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_108;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_108;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_15;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_15;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_84;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_84;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_101;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_101;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_107;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_107;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_109;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_109;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_110;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_110;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_111;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_111;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_113;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_113;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_114;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_114;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_115;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
anonymized_name=W6L6K8;subject_id=ML_115;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_117;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_117;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_121;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_121;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_123;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_123;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_124;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_124;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_125;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_125;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_126;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_126;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_128;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_128;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_130;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_130;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_131;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_131;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_04;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_132;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_133;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_133;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_135;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_135;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_26;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_26;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_35;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_35;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_48;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_48;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_56;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_56;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_57;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_57;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_58;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_58;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_60;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_60;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_65;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_65;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_71;gender=male;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_71;gender=male;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_90;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_90;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
subject_id=ML_136;gender=female;phenotype=non-tumor;sample type=blood;ENA-CHECKLIST=ERC000026;
subject_id=ML_136;gender=female;phenotype=tumor;disease_site=skin;ENA-CHECKLIST=ERC000026;
